iTeos Therapeutics CEO Michel Detheux's 2021 pay falls 67% to $5.6M
iTeos Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
iTeos Therapeutics reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, three executives at iTeos Therapeutics received on average a compensation package of $5M, a 26% decrease compared to previous year.
Average pay of disclosed executives at iTeos Therapeutics
Michel Detheux, Chief Executive Officer, received $5.6M in total, which decreased by 67% compared to 2020. 83% of Detheux's compensation, or $4.7M, was in option awards. Detheux also received $301K in non-equity incentive plan, $525K in salary, as well as $110K in other compensation.
Joanne Jenkins Lager, Chief Medical Officer, received a compensation package of $5M, which increased by 286% compared to previous year. 87% of the compensation package, or $4.4M, was in option awards.
Matthew Call, Chief Operating Officer, earned $4.2M in 2021.
Related executives
You may also like
Source: SEC filing on April 25, 2022.